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ORIGINAL ARTICLE
Knowledge, attitude and perceptions of Muslim cancer patients regarding cancer
treatment during Ramadan: Results from a tertiary care hospital Karachi
Afshan Asghar Rasheed,1 Yasmin Abdul Rashid,2 Farah Tahir Pirzada,3 Fawad Haroon,4 Adnan Abdul Jabbar,5 Ahmed Rahim6

Abstract
Objective: To assess the knowledge and attitude of Muslim cancer patients regarding cancer treatment during
Ramadan.
Methods: This cross-sectional study was conducted at the Aga Khan University Hospital, Karachi, from July to
August 2015, and comprised cancer patients. .Adult Muslim cancer patients receiving active oncological treatment
or on surveillance were included. Patients on only supportive treatment were excluded. SPSS 19 was used for data
analysis.
Results: Of the 265 patients, 87(32.8%) were males and 178(67.2%) were females. The overall mean age was
49±13.87 years. Besides, 184(70.9%) patients belonged to the middle class. Breast cancer was the most common
cancer 106(40.6%). Overall, 153(57.9%) patients had stage II disease. Further, 201(80%) patients had 0-1
performance status. Moreover, 180(72%) patients were receiving different forms of chemotherapeutic agents. It was
found that 113(54.3%) patients sought advice regarding fasting. Most of the patients who observed fast, i.e.
214(81%), had an early stage disease and 19(7.1%) were on hormonal therapy. Patients who did not fast mostly
attributed this to fatigue 69(26.3%).
Conclusion: Only half of the patients sought advice on fasting and those having early disease more frequently
observed fast.
Keywords: Ramadan, Chemotherapy, Fasting, Perceptions. (JPMA 67: 1144; 2017)

Introduction
Ramadan is the ninth lunar month of the Muslim
calendar, when it is compulsory for all healthy adult
Muslims to withhold from food and drink from dawn to
sunset daily.1 Islam gives provision of not fasting for
individuals for whom it may cause harm, for example
those suffering from acute or chronic diseases.2 Despite
the leniency in Islamic rules, some cancer patients wish to
follow their religious tradition of fasting during
Ramadan.3 The issue of fasting during Ramadan has great
importance for Muslim cancer patients, often putting
them in a stressful situation. At times they fail to consult
health care practitioners, family and friends or religious
scholars, regarding fasting and feel guilty if they do not
fast.4 In Egypt, 46% cancer patients consulted the doctor
about fasting, while only 20.8% of the Turkish Muslim
patient population sought a physician's advice regarding
fasting.4
Cancer is a complex disease having a multi-faceted
aetiology, including genetic, lifestyle and environmental
factors.1 European Prospective Investigation into Cancer
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and Nutrition (EPIC) study observed significant
association between some malignancies and dietary
habits.2 After a short-term, controlled starvation for 48
hours, cancer cells were affected up to 1,000 times more
than normal cells from the effects of chemotherapy and
oxidative stress, a phenomenon termed as Differential
Stress Resistance.4 Islam gives provision for not fasting, if
this would be harmful to person in acute or chronic
disease.5 However, some cancer patients still wish to
follow their religious tradition of fasting during
Ramadan.6 In a study by Raffaghello et al., 10 patients
who fasted in combination with chemotherapy reported
that fasting caused a reduction in side effects of therapy.3
In one study by Fernando M, Safdie et al., fasting was
safely repeated in multiple cycles for up to 180 hours
prior and/or following chemotherapy.4 Complaints
reported during fasting were dizziness, hunger and
headache, which did not interfere with daily routine
activities. Weight lost was also regained in most of the
patients.4 Therefore, perceived adverse effects of
chemotherapy on cancer patients who were fasting were
short-lived.
Pakistan is the second-largest Muslim nation in the world
and a member of the South Asian Association for
Regional Cooperation(SAARC).7 The country's population
was 173 million in 2008,8 of whom 97 percent people
J Pak Med Assoc
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were Muslim.9 Noronha et al. reported 150,000 new
cancer cases each year in Pakistan.10 Many Muslims with
chronic illness like cancer practise fasting during the
month of Ramadan.11 There is sparse data to select
cancer patients who can tolerate fasting.6 To the best of
our knowledge, there is no study conducted on cancer
patients to assess their knowledge and practices
regarding fasting. It is believed that the masses are aware
of the generalised benefits of fasting, but the precise
benefits of controlled starvation with cancer treatment
are not well known. The current study was planned to
explore the knowledge, attitude and perceptions of
Pakistani Muslim cancer patients about cancer treatment
during Ramadan.

Patients and Methods
This cross-sectional study was conducted at the clinics of
medical oncology unit of the Aga Khan University
Hospital (AKUH), Karachi, from July to August 2015
coinciding with the month of Ramadan, and comprised
cancer patients.
Adult Muslim cancer patients receiving active oncological
treatment or on surveillance were included. Patients on
only supportive treatment were excluded.
Fasting was defined according to Islamic rules, i.e.
abstaining from drinking, eating and smoking from
dawn to sunset. Eastern Cooperative Oncology Group
(ECOG) Performance status was defined according to
the World Health Organisation's (WHO) classification.12
According to WHO, ECOG performance status is divided
into 5 groups. ECOG-0 means fully active. ECOG-1
means restricted in physically sternous activity. ECOG 2
is ambulatory and capable to do carry out all self care
but unable to carry out any work, up and about more
then 50% of day time. ECOG 3 defined as bed bound
more then 50 % of waking hours. ECOG 4 is totally
confined to bed, unable to do own care. ECOG 5 means
death
The sample size was calculated using WHO software for
sample size calculation.13 A sample size of 267 was
required to measure fasting among cancer patients based
on expected prevalence of 50% at 95% confidence level
with 6% margin of error. Expected proportion of 50% was
taken to have the maximum sample size.
Participants were recruited consecutively through nonprobability sampling. Data was collected by authors
using a structured questionnaire which was adopted
from the study by Faukh Tas et al.14,15 The questionnaire
was translated into native language, i.e. Urdu. All the
questionnaires were first tested on a pilot of 10
Vol. 67, No. 8, August 2017

patients from the oncology clinics at the AKUH. After
the pilot, a similar technique was used to collect data
from the study population. The questionnaire
consisted of questions including demographics, comorbidities, performance status and date of diagnosis,
type and stage of cancer, current oncologic treatment
and intent of treatment. The second part related to
perceptions of patients regarding fasting during
Ramadan. Patients were asked about fasting status at
the time of interview, history of side effects of
oncologic treatment before Ramadan, whom they
consulted for fasting and the reasons for not fasting.
We divided the socioeconomic group into upper class
(people earning more than Rs40,000 per month),
middle class (earning Rs20,000-40,000 per month)and
lower class (earning less than Rs20,000 per month).16
Patients were labelled as literate if they had
matriculation or equivalent degree.
Data entry was conducted by two separate groups of
individuals to minimise errors. Data was analysed using
SPSS 19. Continuous data, such as patients' age, was
presented as mean ± standard deviation (SD).
Categorical values were presented as frequencies. For
comparison of sub-groups, chi-square test was used for
categorical values. The independent t-test was applied
for comparing continuous variables. Comparison was
made on the basis of gender, age and type of cancer
treatment being received and the association of these
factors with the patient's perspective towards fasting in
Ramadan. P<0.05 was considered significant for all
statistical analyses.
The study was approved by the institutional ethics review
committee, and informed consent was taken from all the
participants. Patients were assured that refusal to
participate in the study would not lead to loss of benefit
at the respective hospital of which patients are otherwise
entitled to.

Results
Of the 270 participants who gave consent and were
interviewed, 265(98.15%) were included. Of them,
87(32.8%) patients were males and 178(67.2%) were
females. The overall mean age was 49±13.2 years (range:
18 to 80 years). Moreover, 188(70.9%) participants
belonged to the middle class, 39(15%) to the lower class
and 36(13.9%) to the upper class. Among female
patients, 105(59%) were housewives. Out of the total
population, 31(11.7%) were businessmen, 12(11.7%)
physicians, 6(2.3%) engineers, 3(1.5%) retired and
47(18%) belonged to other professions. Also, 237(89.5%)
participants were married, 2(0.8%) were separated, and
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Table-2: Attitude and perceptions of Muslim cancer patients during Ramadan.

Table-1: Demographics of Muslim cancer patients.
Variable

Frequency (100%)
n-265

Age

Mean(SD)
<50 years
>50 years
Male
Female
Literate
Illiterate.
Housewife
Business
Doctor
Engineer
Others
ECOG I
ECOG II
Breast
GI
Lymphoma
Buccal Mucosa
Others

49.5+/- 13.8
133(50.2%)
132(49.8%)
88(33%)
178(66.9%)
228(86%)
37(14%)
157 (59%)
31 (11.7%)
12 (4.5%)
6 (2.3%)
59 (22.2%)
212 (79.7%)
54 (20.3%)
108 (40.6%)
37 (13.9%)
39 (14.7%)
26 (9.8%)
56 (21%)

Hormonal therapy
Chemotherapy
Others

16(6%)
186(70%)
8 (5%)
55(20 % ) were not
receiving any treatment

Capecitabine
Tamoxifen/Femara
Others
Upper class
Middle class
Lower class

10(3.8%)
18(6.8%)
24(9%)
37 (13.9%)
188 (70.9%)
40 (15%)

Gender
Education
Occupation

Performance Status
Type of cancer

Current Oncologic treatment
(n-215,-81%)

Oral –Chemo/hormonal
(n-50, 19%)

Socioeconomic condition

ECOG: Eastern Cooperative Oncology Group
GI: Gastrointestinal
SD: Standard Deviation.

22(8.6%) were single (Table-1).
Furthermore, 167(63.2%) patients had no associated comorbidities, 47(18%) had hypertension and 21(8.3%)
had diabetes mellitus. The most common malignancy
was breast cancer 106(40.6%), followed by
gastrointestinal malignancies 36(13.9%). Besides,
153(57.9%) participants had stage II disease at the time
of the interview. The number of patients receiving
different forms of chemotherapy was 180(72%). The
most common intravenous chemotherapy was
doxorubicin and cyclophosphamide in 30(16.5%)
patients, followed by carboplatin and paclitaxel in
19(10.5%) patients, whereas 35(19.4%) patients were
receiving other forms of chemotherapy. Also, 42(23.8%)
patients were cured on Single-agent chemotherapy.

Variable

N-265(100%)

Did you seek advice for fasting
Yes
144(54.3%)
No
121(45.6%)
If you did seek advice, suggestion of respective advisors
Discouraged
73(27.4%)
Encouraged
24(9%)
Equivocal
32(12%)
If fasting then how many days would like to fast during Ramadan (n-72, 27%)
All days
26(9.8%)
Most of the days
46 (17.3%)
Not fasting secondary to
Allowed in Islam
81 (30.6%)
Nausea/vomiting/diarrhoea
54(20.3%)
Others
130(49%)
How do you feel if not fasting
Guilty
29(10.9%)
Sad
59(22.3%)
At piece
78 (66.9%)
If fasting, how do you feel
Content
213(80.1%)
Stress
36(13.5%)
No effect
17(6.4%)
What do you think, with fasting side effects of chemotherapy
Aggravate
135 (50.9%)
Alleviate
32 (12.1%)
No effect
98(36.9%)
If fasting attitude would be
Positive
196(73.7%)
Negative
29(10.9%)
No effect
41(15.4%)

Oral chemotherapy was taken by 35(19.6%) patients.
Hormonal therapy encompassed 19(7.1%) of the study
participants. The intent of treatment was found to be
curative in 177(66.9%) patients.
Moreover, 144(54.3%) patients sought advice
regarding fasting; 50(18.8%) consulted a physician,
66(25%) discussed with their family members and
20(7.5%) discussed with their physician and family
both. Besides, 8(3%) patients consulted their Imam
(religious scholar).Out of the population of respective
advisors, only 24(9%) had encouraged fasting and
72(27%) advised against it. Most of the patients
followed their respective advisor's suggestions.
Furthermore, 72(27%) patients were fasting at the time
of interview. Among them, 26(9.8%) wished to fast
throughout Ramadan. The 215(81%) patients who
observed fast at the time of interview had early stage
disease, i.e. stage I or II.
Patients who did not fast mostly attributed this to fatigue
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Table-3: Comparison of fasting vs. non fasting patients.
Characteristic

Education
Literate
Illiterate
Age
<50 years
>50 years
Gender
Male
Female
Socioeconomics
Upper
Middle
Lower
Occupation
Housewife
Doctor/Engineer
Others
Type of cancer
Breast
Lymphoma
Others
Current oncologic treatment
Hormonal
Chemo/targeted
Others

Fasting at the time of interview

Chi-square

P-value*

161(61%)
30(11.3%)

1.019

0.601

41(15%)
7(2.6%)

94(35%)
97(37%)

12.5

0.289

16(6%)
58 (22%)

71(27%)
120(45%)

5.7

0.021

12(4.5%)
53(20%)
9(3.4%)

25(9.4%)
131(49.4%)
35(13.2%)

0.81

0.66

51(19%)
8 (3%)
15(6%)

103(39%)
10 (4%)
74 (28%)

12.84

0.045

48(18%)
11(4%)
15(6%)

58(22%)
27(10%)
106(40%)

29.04

0.001

44(17%)
31(12%)
9(3%)

4 (1%)
152(57%)
35 (13%)

11.7

0.02

Yes

No

67(25%)
7(2.6%)

70(26.3%). Besides, 62(23.3%) patients believed that
being sick did not mandate them to fast. Also, 27(10.2%)
and 15(5.3%) patients cited nausea and vomiting,
respectively, to be a concerning side effect that would
interfere with fasting. Only 26(9%) patients skipped
fasting due to the common belief that intravenous
chemotherapy would break the fast and 20(7.6%)
attributed it to diarrhoea and pain as the reason for not
fasting.
Among other perceptions, 215(81%) patients felt
comfortable in telling others that they were not fasting;
192(72%) patients who did not observe fast confessed
that they would have been more satisfied if they observed
fast; 160(60.5%) patients gave the impression that fasting
would have interfered with their cancer treatment;
232(87.6%) patients expressed the desire that if they were
given a choice, they would have continued treatment
with fasting; 240(94.4%) believed that fasting would have
spiritually strengthened them and hastened the healing if
they would have observed fast (Table-2).
In the subgroup analysis for perceptions of patients,
statistically significant difference was observed between
some variables. Patients who sought advice about fasting
Vol. 67, No. 8, August 2017

strictly followed their advisor's recommendations
(p=0.005). Subjects who did not fast believed that the side
effects of chemotherapy would have worsened during
fasting (p=0.001). The most common reason to skip fast
was vomiting and fatigue (p=0.003). Non-fasting patients
felt guilty in comparison to patients who did fast
(p=0.014). Patients expressed their faith that fasting can
hasten their healing (p=0.05). We did not find any
difference between people who sought advice and did
fast compared to non-fasting patients who did not
consult anyone regarding this (p=0.0.36). Other questions
related to perceptions, i.e. whether patients were
comfortable in telling others about not fasting,
continuation of treatment during fasting and whether
fasting could interfere with oncological treatment, did not
show any notable difference statistically (p=0.23).
A comparison of fasting and non-fasting patients at the
time of interview on the basis of their demographics,
perceptions and attitude was done. We found statistically
significant differences in fasting between the two genders
(p=0.016). Housewives, females with breast malignancy,
early stage cancer patients and those having ECOG
performance status 0-1 were also found to be in a better
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state to fast in comparison to other kinds of occupations,
cancers and advanced stage disease (p<0.05). However,
variables such as education, economic status, co-morbid
conditions and age group did not show a significant
difference (p=0.36). We did not find any difference based
on ethnicity. On the other hand, patients on oral
hormonal therapy showed a significant difference with
fasting than the ones receiving intravenous or oral
chemotherapy (p=0.03) (Table-3).

Discussion
Fasting is one of the five pillars of Islam; hence it is a
distinctive spiritual characteristic of this religion. Therefore,
many Muslim patients, as per their religious spirit, insist to
observe fast even though Islam gives them liberality from
fasting because of their ill health.17,18 Muslim cancer
patients are amongst those who want to observe fast
during Ramadan.19 In medical literature, there is sparse
data about fasting during active oncological treatment
and no published guidelines are available.
In the context of medical element, we assessed the
knowledge, attitude and perceptions of our Muslim
cancer patients about fasting during Ramadan (July). As
per our literature search, we found studies postulating
the positive effects of fasting on cancer treatment.20
Raffaghello L. et al. highlighted the fact that fasting
effectively improved burden of cancer by creating fastinduced stress resistance for malignant cells.21 Safdie and
Bradhorst in their study also brainchild the phenomenon
of starvation to induce death of cancer cells.22 Moreover,
a case report by M. Safdie and Tanya Dorff endorsed the
fact that fasting alleviates the side effects of
chemotherapy in a cancer patients.4
Among the surveyed group, the majority (60%) of the
population did not fast due to exceptionally high hot
weather conditions i.e. >40°C. This heat wave
shadowed the holy month of year 2015, affecting the
health of the normal healthy population and thus
being a cause for sickness and extreme exhaustion. In
our study, females (66.7%) were the dominant gender,
with breast cancer (40.6%) being the most common
malignancy. Among patients who practised fast, 80%
were females and 79% amongst them were on
hormonal treatment. There was a significant difference
between female gender and breast cancer during
fasting (p<0.05). It might be secondary to the fact that
most females were housewives, had early stage disease
and were taking hormonal therapy that can be taken at
any time in non-fasting hours. These results were
consistent with the findings observed in a Turkish
study, in which patients on hormonal therapy with
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urogenital cancer practised fast comparatively more
than other malignancies.15 In case of breast carcinoma,
we noticed patients having good performance status
till advanced stage of their disease in comparison to
other malignancies and because of good physical
condition they managed to tolerate fast while receiving
chemotherapy. In Groot et al’s. pilot study, 7 out of 13
breast carcinoma patients tolerated chemotherapy
well.23 In our study, 14 out of 72 (19.4%) patients
receiving intravenous chemotherapy did fast, among
them 12(6%) had early stage breast carcinoma and
were receiving doxorubicin and cyclophosphamide.
But there was no statistical difference between
different intravenous chemotherapy regimens (p0.104). It has been observed in other chronic diseases
that young patients fast more than older ones because
of frequent co-morbidities in the elderly.15 In our study,
149(56 %) fasting patients belonged to less than 50
years of age, but this was statistically insignificant
(p=0.36). Similarly, it was perceived that people with
good performance status and non-metastatic disease
would fast more than the opposite group.24 In this
study, patients with ECOG 0-1 and early-stage cancer
observed fast more often in comparison to their
counterparts (100%). All these factors, i.e. cancer stage
and performance status, showed statically significant
values (p<0.05). In Zeeneldin et al’s. study, 46% patients
sought advice from their oncologist.13 In our study,
50(18.8%) patients discussed fasting with their
physician and 8(3%) consulted Imam (religious
scholar). This indicates their trust in treating physicians.
Moreover, 67(25%) patients discussed the issues with
their family members and physicians both for fasting,
though 133(50%) were discouraged by their advisors.
Patients in our study followed suggestion of their
advisors. But 128(48%) did not discuss with anyone
about fasting and its related issues. These patients
expressed guilt for not observing fast. Among them,
191(72%) patients said they would have felt content if
they had fasted. Fatigue was found to be the most
common symptom in patients receiving chemotherapy
and this factor affected their quality of life as well.23 In
our study, frequently reported symptoms for not
fasting were fatigue (26%) and nausea/ vomiting (10%).
It is generally believed that intravenous medicines
interfere with fasting, therefore, people cannot observe
fast while on any intravenous medicine. In this survey,
24(9%)
patients
thought
that
intravenous
chemotherapy could nullify fast thus they avoided
fasting on the days of chemotherapy. Another major
contributory factor for skipping fast, which was
pointed out by many patients themselves, was hot
J Pak Med Assoc
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weather. Because of unusually increased temperature
in the month of Ramadan in 2015, when the study was
conducted, most of the patients (60%) skipped fasting
as they feared getting dehydrated and hence being
more vulnerable to ongoing disease-/ treatmentrelated side effects. The literature search postulated a
perception that if Muslim patients fasted, God would
be more merciful to them, eventually hastening their
spiritual healing.15 Our study also supports this insight
as 250(94%) patients thought that fasting would
spiritually make them stronger and improve their
illness, even though they were not in a fasting state.
Despite extensive literature search, we found only three
studies addressing the issues of fasting of Muslim cancer
patients during Ramadan. The patient-doctor
relationship has not been discussed extensively. It is
important for patients with any disease to have a good
relationship with their treating physicians, so that they
can discuss their health issues more comfortably.
Similarly, perception and attitude of patients regarding
fasting during Ramadan have not been studied in depth.
Therefore, a proper support system for Muslim cancer
patients should be built up where they can share their
problems and come to solutions. Thus, better
understanding can be developed in patients with
mental and spiritual harmony.

perceptions of patients with advanced stage versus
early stage cancer.

Conclusion
Only half of the patients sought advice about fasting and
those having early disease more frequently observed
fast. These patients require guidance to fulfil their
obligations during this month. For this patients must
have a good support system. The patient-doctor
relationship harbours the key position of this support
system. Therefore, the treating oncologist should
develop better communication with patients so that they
feel more comfortable in discussing their issues. As
patients need good social support while they are
receiving active oncological treatment, family members
and clerics should also be indulged for addressing the
concerns of Muslim cancer patients more specifically
during Ramadan.
Disclaimer: This article has not been presented or
published in a conference, or published in an abstract.
Conflict of Interest: None.
Source of Funding: None.
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